Morgan Stanley
ARTV

Morgan Stanley’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Morgan Stanley’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$69.8K Buy
46,247
+18,427
+66% +$27.8K ﹤0.01% 6251
2025
Q1 		$83.5K Sell
27,820
-9,467
-25% -$28.4K ﹤0.01% 6097
2024
Q4 		$376K Sell
37,287
-2,666
-7% -$26.9K ﹤0.01% 5545
2024
Q3 		$617K Buy
+39,953
New +$617K ﹤0.01% 5304